Brickell Biotech (BBI) Financials

$1.73

$0.00 (0.00%)

As on 09-Nov-2022 09:30EDT

Market cap

$7 Mln

Revenue (TTM)

$5 Mln

P/E Ratio

--

P/B Ratio

0.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Operating Revenue	4.64	0.40	1.82	7.92	1.62	13.82
Cost of Revenue	--	--	--	20.21	1.44	6.48
Gross Profit	4.64	0.40	1.82	7.92	0.19	7.34
Operating Expenses	35.17	40.65	22.80	32.39	21.27	27.21
Operating Profit (EBIT)	-29.97	-39.41	-20.98	-24.47	-19.65	-13.39
Other Income	--	--	0.06	2.70	3.39	0.43
Profit before Tax	-29.88	-39.47	-20.91	-23.88	-16.25	-12.96
Provision for Tax	0.12	0.07	0.06	2.69	4.48	0.43
Profit after Tax (Net Income)	-29.89	-39.54	-20.91	-23.88	-16.25	-12.96
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-29.88	-39.47	-20.91	-13.60	-16.25	-12.96

Liabilities ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Shareholder's Funds	15.64	24.91	27.14	7.57	48.76	63.58
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	1.30	1.67	0.15	0.07	1.74	--
Current Liabilities	2.87	4.81	6.35	10.50	3.58	16.92
Total Liabilities	21.38	29.72	33.63	18.14	52.34	80.49

Assets ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Non-Current Assets	0.26	0.12	0.10	0.18	3.15	4.18
Current Assets	18.25	29.60	33.53	17.97	49.20	76.32
Total Assets	21.38	29.72	33.63	18.14	52.34	80.49
Total Debt*	0.04	0.07	0.51	0.15	4.64	--
Net Current Assets	15.38	24.79	27.18	7.47	45.62	59.40

Cashflow ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Cash From Operating Activities	--	-36.15	-20.03	-35.98	-14.45	-8.60
Cash Flow from Investing Activities	--	-0.04	4.48	32.51	1.28	-5.29
Cash from Financing Activities	--	32.95	38.44	2.64	-1.28	30.55
Net Cash Inflow / Outflow	--	--	22.88	-0.84	-13.16	16.65

Financials Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
ROCE (%)	--	-150.29	-118.25	-78.12	-27.79	-23.84
ROE (%)	-147.43	-151.97	-120.50	-84.76	-28.94	-23.84
ROA (%)	-104.62	-124.84	-80.78	-67.75	-24.47	-19.52
EBIT Margin (%)	-643.25	-9,753.71	-1,147.80	-275.12	-934.90	-93.78
Net Margin (%)	-643.70	-9,787.87	-1,109.44	-224.94	-324.17	-90.98
Cash Profit Margin (%)	-0.02	--	--	--	--	--

Growth Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Revenue Growth (%)	1,277.74	-0.78	-0.77	3.88	-0.88	-0.05
EBIT Growth (%)	6.03	-88.42	3.99	-43.64	-17.01	-44.43
Net Profit Growth (%)	6.15	-89.08	12.41	-46.90	-25.42	-44.43
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Price / Earnings	--	--	--	--	--	--
Price / Book Value	0.41	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.28	0.68	1.42	0.53	2.89	4.97
Close Price ($)	5.67	10.30	35.12	67.50	371.70	576.45
High Price ($)	43.03	76.50	179.10	403.20	604.80	1,165.50
Low Price ($)	4.95	9.99	20.97	54.90	315.00	522.90
Market Cap ($ Cr)	6.75	--	--	--	--	--

Solvency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debt to Equity	--	0.00	0.02	0.02	0.10	--
Short term debt to equity ratio	0.00	0.00	0.01	0.01	0.10	0.03
Current Ratio	6.36	6.15	5.28	1.71	13.74	4.51
Quick Ratio	6.36	--	--	--	14.05	--
Interest Coverage	-2,715.09	-571.09	--	-10.39	-13.91	--

Operating Efficiency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debtors to sales (%)	10.98	--	--	--	69.54	37.08
Asset Turnover	0.16	0.01	0.07	0.22	0.02	0.21
Receivable days	--	--	--	52.04	703.93	185.80
Inventory Days	--	--	--	-20.38	-286.91	--
Payable days	--	--	--	24.00	206.66	43.38
Cash Conversion Cycle	--	--	--	7.65	210.36	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.